Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
US5595985A · kind A · utility
27Cited by
16References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 15, 1993 |
| Grant date | Jan 21, 1997 |
| Priority date | — |
| Expiry date | Dec 15, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J71/001
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia in susceptible warm-blooded animals which comprises administering a combination of two or more compounds selected from the group consisting of an inhibitor of 5.alpha.-reductase activity, an antiestrogen, an inhibitor of aromatase activity, an inhibitor of 17.beta.-hydroxysteroid dehydrogenase activity and, in some cases, an anti-androgen and/or an LHRH agonist. Pharmaceutical compositions useful for such treatment and pharmaceutical kits containing such compositions are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.